353 related articles for article (PubMed ID: 30075004)
1. The selectivity of galardin and an azasugar-based hydroxamate compound for human matrix metalloproteases and bacterial metalloproteases.
Sylte I; Dawadi R; Malla N; von Hofsten S; Nguyen TM; Solli AI; Berg E; Adekoya OA; Svineng G; Winberg JO
PLoS One; 2018; 13(8):e0200237. PubMed ID: 30075004
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of pseudolysin and thermolysin by hydroxamate-based MMP inhibitors.
Adekoya OA; Sjøli S; Wuxiuer Y; Bilto I; Marques SM; Santos MA; Nuti E; Cercignani G; Rossello A; Winberg JO; Sylte I
Eur J Med Chem; 2015 Jan; 89():340-8. PubMed ID: 25462250
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, experimental evaluation and molecular modelling of hydroxamate derivatives as zinc metalloproteinase inhibitors.
Sjøli S; Nuti E; Camodeca C; Bilto I; Rossello A; Winberg JO; Sylte I; Adekoya OA
Eur J Med Chem; 2016 Jan; 108():141-153. PubMed ID: 26638045
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human leukocyte elastase, plasmin and matrix metalloproteinases by oleic acid and oleoyl-galardin derivative(s).
Moroy G; Bourguet E; Decarme M; Sapi J; Alix AJ; Hornebeck W; Lorimier S
Biochem Pharmacol; 2011 Mar; 81(5):626-35. PubMed ID: 21146503
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of bacterial and human zinc-metalloproteases by bisphosphonate- and catechol-containing compounds.
Rahman F; Nguyen TM; Adekoya OA; Campestre C; Tortorella P; Sylte I; Winberg JO
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):819-830. PubMed ID: 33757387
[TBL] [Abstract][Full Text] [Related]
6. Zinc-Chelating Compounds as Inhibitors of Human and Bacterial Zinc Metalloproteases.
Rahman F; Wushur I; Malla N; Åstrand OAH; Rongved P; Winberg JO; Sylte I
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011288
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.
Yamamoto M; Tsujishita H; Hori N; Ohishi Y; Inoue S; Ikeda S; Okada Y
J Med Chem; 1998 Apr; 41(8):1209-17. PubMed ID: 9548812
[TBL] [Abstract][Full Text] [Related]
8. Design of galardine analogs as putative psudolysin inhibitors based on
Ezawa T; Sugiyama S; Ara A; Sylte I; Kurita N
J Biomol Struct Dyn; 2020 Jul; 38(11):3307-3317. PubMed ID: 31422741
[TBL] [Abstract][Full Text] [Related]
9. Simple pseudo-dipeptides with a P2' glutamate: a novel inhibitor family of matrix metalloproteases and other metzincins.
Devel L; Beau F; Amoura M; Vera L; Cassar-Lajeunesse E; Garcia S; Czarny B; Stura EA; Dive V
J Biol Chem; 2012 Aug; 287(32):26647-56. PubMed ID: 22689580
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the binding specificity of two bacterial metalloproteases, LasB of Pseudomonas aeruginosa and ZapA of Proteus mirabilis, using N-alpha mercaptoamide template-based inhibitor analogues.
Carson L; Cathcart GR; Ceri H; Walker B; Gilmore BF
Biochem Biophys Res Commun; 2012 Jun; 422(2):316-20. PubMed ID: 22575503
[TBL] [Abstract][Full Text] [Related]
11. Labeling and enrichment of Arabidopsis thaliana matrix metalloproteases using an active-site directed, marimastat-based photoreactive probe.
Lenger J; Kaschani F; Lenz T; Dalhoff C; Villamor JG; Köster H; Sewald N; van der Hoorn RA
Bioorg Med Chem; 2012 Jan; 20(2):592-6. PubMed ID: 21775155
[TBL] [Abstract][Full Text] [Related]
12. Use of a specific MMP-inhibitor (galardin) for preservation of hybrid layer.
Breschi L; Martin P; Mazzoni A; Nato F; Carrilho M; Tjäderhane L; Visintini E; Cadenaro M; Tay FR; De Stefano Dorigo E; Pashley DH
Dent Mater; 2010 Jun; 26(6):571-8. PubMed ID: 20299089
[TBL] [Abstract][Full Text] [Related]
13. Hydroxamate-based peptide inhibitors of matrix metalloprotease 2.
Jani M; Tordai H; Trexler M; Bányai L; Patthy L
Biochimie; 2005; 87(3-4):385-92. PubMed ID: 15781326
[TBL] [Abstract][Full Text] [Related]
14. A peptide hydroxamate library for enrichment of metalloproteinases: towards an affinity-based metalloproteinase profiling protocol.
Geurink P; Klein T; Leeuwenburgh M; van der Marel G; Kauffman H; Bischoff R; Overkleeft H
Org Biomol Chem; 2008 Apr; 6(7):1244-50. PubMed ID: 18362965
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the binding of hydroxamic acid and carboxylic acid inhibitors to the stromelysin-1 (matrix metalloproteinase-3) catalytic domain by isothermal titration calorimetry.
Parker MH; Lunney EA; Ortwine DF; Pavlovsky AG; Humblet C; Brouillette CG
Biochemistry; 1999 Oct; 38(41):13592-601. PubMed ID: 10521266
[TBL] [Abstract][Full Text] [Related]
16. Amber force field implementation, molecular modelling study, synthesis and MMP-1/MMP-2 inhibition profile of (R)- and (S)-N-hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamides.
Tuccinardi T; Martinelli A; Nuti E; Carelli P; Balzano F; Uccello-Barretta G; Murphy G; Rossello A
Bioorg Med Chem; 2006 Jun; 14(12):4260-76. PubMed ID: 16483784
[TBL] [Abstract][Full Text] [Related]
17. New beginnings for matrix metalloproteinase inhibitors: identification of high-affinity zinc-binding groups.
Puerta DT; Lewis JA; Cohen SM
J Am Chem Soc; 2004 Jul; 126(27):8388-9. PubMed ID: 15237990
[TBL] [Abstract][Full Text] [Related]
18. High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor.
Moy FJ; Chanda PK; Chen JM; Cosmi S; Edris W; Levin JI; Powers R
J Mol Biol; 2000 Sep; 302(3):671-89. PubMed ID: 10986126
[TBL] [Abstract][Full Text] [Related]
19. A new role for old ligands: discerning chelators for zinc metalloproteinases.
Jacobsen FE; Lewis JA; Cohen SM
J Am Chem Soc; 2006 Mar; 128(10):3156-7. PubMed ID: 16522091
[TBL] [Abstract][Full Text] [Related]
20. Effect of galardin on collagen degradation by Pseudomonas aeruginosa.
Hao JL; Nagano T; Nakamura M; Kumagai N; Mishima H; Nishida T
Exp Eye Res; 1999 Dec; 69(6):595-601. PubMed ID: 10620388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
